[ad_1]
The Swiss pharmaceutical company Roche has published the results of a clinical study on a new influenza treatment that has proven effective in people who have had major complications. According to the new study, the new drug "luxafir marboxil" was its main target, as it was found to be more effective in treating influenza than other drugs that could not prevent the virus from infiltrating it. the body. Influenza can cause serious complications in people over 65 or who have asthma, diabetes, chronic lung disease or cardiovascular disease.
[ad_2]
Source link
